Technical Analysis for ABCL - AbCellera Biologics Inc.

Grade Last Price % Change Price Change
F 10.42 -3.61% -0.39
ABCL closed down 3.61 percent on Wednesday, February 8, 2023, on 71 percent of normal volume. The stock fell below its 50 day moving average, damaging its intermediate-term outlook by crossing under that important trendline. The stock fell below its 200 day moving average, damaging its long-term outlook by crossing under that critical trendline.
Earnings due: Feb 21
*** please verify all earnings dates ***

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent Flat Down Down

Date Alert Name Type % Chg
Fell Below 20 DMA Bearish 0.00%
Fell Below 200 DMA Bearish 0.00%
Fell Below 50 DMA Bearish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
Down 3 Days in a Row Weakness 0.00%
50 DMA Support Bullish -3.61%
Bollinger Band Squeeze Range Contraction -3.61%
BB Squeeze Started Range Contraction -3.61%
Overbought Stochastic Strength -3.61%
Stochastic Sell Signal Bearish -5.01%

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
20 DMA Support about 9 hours ago
200 DMA Support about 9 hours ago
Fell Below 200 DMA about 9 hours ago
Down 3% about 9 hours ago
Fell Below 20 DMA about 9 hours ago

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

AbCellera is a technology company that searches, decodes, and analyzes natural immune systems to find antibodies that its partners can develop into drugs to prevent and treat disease. AbCellera partners with drug developers of all sizes, from large pharmaceutical to small biotechnology companies, empowering them to move quickly, reduce cost, and tackle the toughest problems in drug development.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Biotechnology Life Sciences Disease Health Sciences Pharmacy Antibodies Medication Drug Development Pharmacology Pharmaceutical Sciences

Is ABCL a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 14.97
52 Week Low 5.42
Average Volume 1,829,894
200-Day Moving Average 10.43
50-Day Moving Average 10.62
20-Day Moving Average 10.49
10-Day Moving Average 10.74
Average True Range 0.49
RSI 47.92
ADX 14.33
+DI 21.93
-DI 20.56
Chandelier Exit (Long, 3 ATRs) 9.89
Chandelier Exit (Short, 3 ATRs) 10.64
Upper Bollinger Bands 11.19
Lower Bollinger Band 9.78
Percent B (%b) 0.45
BandWidth 13.54
MACD Line 0.10
MACD Signal Line 0.04
MACD Histogram 0.061
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 11.34
Resistance 3 (R3) 11.42 11.19 11.18
Resistance 2 (R2) 11.19 10.96 11.15 11.13
Resistance 1 (R1) 10.81 10.82 10.70 10.73 11.08
Pivot Point 10.58 10.58 10.53 10.54 10.58
Support 1 (S1) 10.20 10.35 10.09 10.12 9.76
Support 2 (S2) 9.97 10.21 9.93 9.71
Support 3 (S3) 9.59 9.97 9.66
Support 4 (S4) 9.51